Americans have been engaged in a detailed and politically charged debate about healthcare reform for the past few years, but there has been surprisingly little discussion about ways new technologies such as regenerative medicine can improve clinical care and reduce spending. These innovative technologies may represent our best hope for dealing with the challenges – primarily due to an ageing population – that lie ahead
...
Regulatory Affairs Medtech
Advancing regenerative medicine in the US requires regulatory change
27 April 2011
Michael J Werner
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Medtech
RELATED CONTENT
NEWS
Regulatory Affairs Medtech News
Other Informa News
ANALYSIS
Other Informa Analysis
EDITORIALS
Other Informa Editorials
FEATURES
Other Informa Features
COMMENT
Other Informa Comments
EVENTS
21September 2009
Minneapolis (MN), US
